Screening for Anthracycline‐Related Cardiac Dysfunction in Childhood Cancer Survivors: Can Less be More?

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|12|2067-2068

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.12, 2015-12, pp. : 2067-2068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of anthracycline‐related cardiac dysfunction in long‐term survivors of adult‐onset lymphoma

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 850-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2197-2203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing anthracycline‐treated childhood cancer survivors with advanced stress echocardiography

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 502-508

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 123-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subclinical anthracycline‐induced cardiotoxicity in long‐term follow‐up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 35, Iss. 2, 2018-02 ,pp. : 234-240

John Wiley & Sons Inc

Access to resources Recommend Favorite